Reports
Sale
Global Biosurgery Market Share, Analysis, Report, Growth, Forecast: By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Haemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement; By Application: Orthopaedic Surgery, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Biosurgery Market Outlook
The global biosurgery market size attained a value of USD 15.44 billion in 2023, driven by the rising use of biosurgery products to prevent excessive blood loss during surgeries and improve efficiency. The market is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032 to attain a value of USD 35.39 billion by 2032.
Rising Preference for Biosurgeries is Augmenting the Market Growth
The global market for biosurgery is being driven by the flourishing healthcare sector around the world. Owing to different factors such as old age, accidents, musculoskeletal disorders, among others, surgical procedures are augmenting the demand for biosurgery products, thereby invigorating the market growth. Biosurgery aids in preventing excessive blood loss during surgeries, thus preventing fatalities during the surgical procedure, thereby incrementing the efficiency of the surgeons.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Moreover, several technological advancements, including the development of plasma-based, multifunctional and multi-use products for biosurgeries are accelerating the market growth. In addition to this, biosurgery products that favour accelerated healing and reduction in post-op recovery are additional factors influencing the growth of the market.
Biosurgery: Market Segmentation
Biosurgery refers to a medical procedure involving the use of sterile maggots to treat patients with infected wounds, primarily in cases when the infection is resistant to traditional antibiotic treatment.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of product, the market can be divided into:
- Bone-Graft Substitutes
- Soft-Tissue Attachments
- Haemostatic Agents
- Surgical Sealants and Adhesives
- Adhesion Barriers
- Staple Line Reinforcement
Based on application, the market can be categorised into:
- Orthopaedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynaecological Surgery
- Others
The EMR report looks into the regional markets of biosurgery like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Advancements in Healthcare Structure to Boost the Market growth of Biosurgery
The market growth of biosurgery can be attributed to advancements in the field of surgeries in the recent years. The introduction of surgical robots has led to a surge in the number of surgeries as robotic surgery minimises human contact and is driven on advanced computing technologies, which reduces the risk of error. Thus, these advancements are pushing the demand for biosurgery products and positively influencing the market growth. Furthermore, the rising adoption of biosurgeries for effective blood loss management through minimally invasive haemostatic agents and surgical sealants instead of conventional staples and sutures is another factor providing impetus to the market. In addition to this, the market growth can further be associated with robust investments into the healthcare structure and various research and development (R&D) activities.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Global Biosurgery Market
The report presents a detailed analysis of the following key players in the global biosurgery market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Baxter International Inc.
- Medtronic PLC
- B. Braun Melsungen AG
- Johnson and Johnson Services, Inc.
- CryoLife Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biosurgery Market Overview
3.1 Global Biosurgery Market Historical Value (2017-2023)
3.2 Global Biosurgery Market Forecast Value (2024-2032)
4 Global Biosurgery Market Landscape
4.1 Global Biosurgery Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biosurgery Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Biosurgery Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biosurgery Market Segmentation
6.1 Global Biosurgery Market by Product
6.1.1 Market Overview
6.1.2 Bone-Graft Substitutes
6.1.3 Soft-Tissue Attachment
6.1.4 Haemostatic Agents
6.1.5 Surgical Sealants and Adhesives
6.1.6 Adhesion Barriers
6.1.7 Staple Line Reinforcement
6.2 Global Biosurgery Market by Application
6.2.1 Market Overview
6.2.2 Orthopaedic Surgery
6.2.3 General Surgery
6.2.4 Neurological Surgery
6.2.5 Cardiovascular Surgery
6.2.6 Gynaecological Surgery
6.2.7 Others
6.3 Global Biosurgery Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Others
6.4 Global Biosurgery Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Biosurgery Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biosurgery Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biosurgery Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biosurgery Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biosurgery Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Baxter
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BD
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Johnson & Johnson Services, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 B. Braun Melsungen AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 CryoLife, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Stryker Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Integra LifeSciences Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hemostasis, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 CSL Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 AROA BIOSURGERY LIMITED
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 TELA Bio, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Tissue Regenix
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Osiris Therapeutics, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Biosurgery Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
Globally, Biosurgery Market market reached a value of USD 15.44 billion in 2023.
The market is projected to expand at a CAGR of 7.2% from 2024 to 2032, growing to USD 35.39 billion by 2032.
The market is being driven by the rising use of biosurgery products to prevent excessive blood loss during surgeries and improve efficiency.
The market growth is anticipated to be defined by the technological advancements, such as the introduction of surgical robots and minimally invasive methods.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of biosurgery are bone-graft substitutes, soft-tissue attachments, haemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcements.
The significant applications of biosurgery include orthopaedic surgery, general surgery, neurological surgery, cardiovascular surgery, and gynaecological surgery, among others.
The major players in the industry are Baxter International Inc., Medtronic PLC, B. Braun Melsungen AG, Johnson and Johnson Services, Inc., and CryoLife Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER